Literature DB >> 17897498

NOS evaluations in human dental pulp-capping with MTA and calcium-hydroxide.

C D'Arcangelo1, F Di Nardo-Di Maio, C Patrono, S Caputi.   

Abstract

The aim of this study is to compare mineral trioxide aggregate (MTA) with calcium hydroxide when used as pulp-capping material in human teeth. 40 teeth were divided into groups based on clinical diagnosis: healthy and hyperaemic. The teeth were pulp capped with MTA and calcium hydroxide. We localized the eNOS and iNOS by immunohistochemistry, tested their mRNA expression by RT-PCR and protein levels by western blots. The evaluation of the samples was based on the cell inflammatory response and on the pulp tissue organization. In particular, evaluation of eNOS and iNOS differences between the various groups and the cellular evolution after the first 7 days from the treatment, and at a distance of 28 days. Our results suggest that there are differences in localization and expression between eNOS and iNOS in dental pulp. Our study has helped us to better understand the effects that calcium hydroxide and MTA have on pulp tissue.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17897498     DOI: 10.1177/039463200702001s07

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  3 in total

1.  Evaluation of mineral trioxide aggregate (MTA) versus calcium hydroxide cement (Dycal(®) ) in the formation of a dentine bridge: a randomised controlled trial.

Authors:  Fatou Leye Benoist; Fatou Gaye Ndiaye; Abdoul Wakhabe Kane; Henri Michel Benoist; Pierre Farge
Journal:  Int Dent J       Date:  2012-02       Impact factor: 2.607

Review 2.  Production and physiological role of NO in the oral cavity.

Authors:  Kimiharu Ambe; Hiroki Watanabe; Shinya Takahashi; Toshihiro Nakagawa; Junzo Sasaki
Journal:  Jpn Dent Sci Rev       Date:  2015-09-11

3.  Which is the most effective biomaterial in indirect pulp capping? 4- year comparative randomized clinical trial.

Authors:  Uzay Koc Vural; Arlin Kiremitci; Saadet Gokalp
Journal:  Eur Oral Res       Date:  2022-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.